SUMMARY
Svetomir N. Markovic, M.D., Ph.D., is an oncologist and scientist whose research centers on translational immunotherapeutics for cancer, with a main focus on melanoma.
Dr. Markovic investigates how cancer cells evade the immune system. He uses this research knowledge to advance the discovery and clinical testing of novel agents that harness the immune system to fight cancer, aiming to create treatments that are more effective and less toxic.
Dr. Markovic also is the principal investigator of the Melanoma Research Laboratory, which focuses on developing novel treatments for metastatic melanoma.
His career has been dedicated to transforming patient care and advancing medical innovation. He has mentored numerous physicians and researchers and holds hundreds of patents and licensed technologies.
Focus areas
- Discovery of biological processes that cancer cells use to overcome antitumor immunity, with emphasis on the tumor microenvironment and tumor-draining lymph nodes.
- Discovery and translation into clinical studies of novel agents that use the immune system to treat advanced melanoma.
- Nanoparticle engineering and drug delivery.
Significance to patient care
Dr. Markovic's goal is to gain a better scientific understanding of how cancer cells avoid the immune system. He wants to create new treatments that use the immune system to fight cancer. These kinds of treatments might be more effective and less harmful to patients.
Professional highlights
- Mayo Clinic:
- Chair, Automation, Innovation and Transformation, 2025-present.
- Charles F. Mathy Professor of Melanoma Research, 2009-present.
- Distinguished Inventor Award, 2024.